Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 3 |
2020 | 1 |
2021 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway.
Cancers (Basel). 2023 Aug 25;15(17):4252. doi: 10.3390/cancers15174252.
Cancers (Basel). 2023.
PMID: 37686528
Free PMC article.
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition.
Borenäs M, Umapathy G, Lind DE, Lai WY, Guan J, Johansson J, Jennische E, Schmidt A, Kurhe Y, Gabre JL, Aniszewska A, Strömberg A, Bemark M, Hall MN, Eynden JVD, Hallberg B, Palmer RH.
Borenäs M, et al.
Proc Natl Acad Sci U S A. 2024 Jan 2;121(1):e2315242121. doi: 10.1073/pnas.2315242121. Epub 2023 Dec 28.
Proc Natl Acad Sci U S A. 2024.
PMID: 38154064
Free PMC article.
Item in Clipboard
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.
Borenäs M, Umapathy G, Lai WY, Lind DE, Witek B, Guan J, Mendoza-Garcia P, Masudi T, Claeys A, Chuang TP, El Wakil A, Arefin B, Fransson S, Koster J, Johansson M, Gaarder J, Van den Eynden J, Hallberg B, Palmer RH.
Borenäs M, et al.
EMBO J. 2021 Feb 1;40(3):e105784. doi: 10.15252/embj.2020105784. Epub 2021 Jan 7.
EMBO J. 2021.
PMID: 33411331
Free PMC article.
Item in Clipboard
Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells.
Cervantes-Madrid D, Szydzik J, Lind DE, Borenäs M, Bemark M, Cui J, Palmer RH, Hallberg B.
Cervantes-Madrid D, et al. Among authors: borenas m.
Sci Rep. 2019 Dec 18;9(1):19353. doi: 10.1038/s41598-019-55060-7.
Sci Rep. 2019.
PMID: 31852910
Free PMC article.
Item in Clipboard
Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells.
Alam MW, Borenäs M, Lind DE, Cervantes-Madrid D, Umapathy G, Palmer RH, Hallberg B.
Alam MW, et al. Among authors: borenas m.
Front Oncol. 2019 Jul 5;9:579. doi: 10.3389/fonc.2019.00579. eCollection 2019.
Front Oncol. 2019.
PMID: 31334113
Free PMC article.
Item in Clipboard
Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements.
Javanmardi N, Fransson S, Djos A, Umapathy G, Östensson M, Milosevic J, Borenäs M, Hallberg B, Kogner P, Martinsson T, Palmer RH.
Javanmardi N, et al. Among authors: borenas m.
Genes Chromosomes Cancer. 2020 Jan;59(1):50-57. doi: 10.1002/gcc.22790. Epub 2019 Sep 2.
Genes Chromosomes Cancer. 2020.
PMID: 31340081
Item in Clipboard
Cite
Cite